Product Information
CETIRIZINE HCL 10 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0640 per EA under NDC 70010016305. Its NADAC has been published 209 times since Jun 29, 2022.
Strength
10 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010016305
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209274On Market Since
1/13/2022
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 10 MG TABLET has been published 209 times since Jun 29, 2022, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0640 per EA |
|---|---|
| All-time high | $0.0734 (Jul 13, 2022) |
| All-time low | $0.0539 (Jul 17, 2024) |
| 52-week high | $0.0721 |
| 52-week low | $0.0602 |
| Median price | $0.0662 |
| Average price | $0.0653 |
| Largest weekly change | +24.2% (Aug 21, 2024) |
| Weeks tracked | 209 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 10 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.0640 per EA (NDC 70010016305), effective Jun 24, 2026.
How has the price of CETIRIZINE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 10 MG TABLET has declined 12.8%. It has been tracked across 209 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 10 MG TABLET?
Since Jun 29, 2022, the NADAC for CETIRIZINE HCL 10 MG TABLET has ranged from a low of $0.0539 (Jul 17, 2024) to a high of $0.0734 (Jul 13, 2022), with a median of $0.0662 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 10 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CETIRIZINE HCL 10 MG TABLET, but none are currently priced below it.
Who manufactures CETIRIZINE HCL 10 MG TABLET?
CETIRIZINE HCL 10 MG TABLET (NDC 70010016305) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification